Index of reports
> Life Threatening Events (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Actiq (Fentanyl Oral Transmucosal) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Actiq side effects in male
Reported by a physician from Italy on 2012-08-01
Patient: male
Reactions: Sopor, Loss of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Actiq
Other drugs received by patient: Albumina Umana; MS Contin; Cyclophosphamide; Rocephin; Dexamethasone Sodium Phosphate
Possible Actiq side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-23
Patient: male
Reactions: Overdose, Pneumonia Aspiration, Coma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Aspirin
Administration route: Oral
Indication: Platelet Aggregation Inhibition
Novorapid
Indication: Diabetes Mellitus
Duragesic-100
Indication: Pain
End date: 2010-03-30
Creon
Administration route: Oral
Indication: Pancreatitis
Actiq
Administration route: Oral
Indication: Pain
End date: 2010-03-30
Lantus
Indication: Diabetes Mellitus
Possible Actiq side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20
Patient: 59 year old male
Reactions: Coma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Duragesic-100
Indication: Pain
End date: 2010-03-30
Novorapid
Actiq
Indication: Pain
End date: 2010-03-30
Lantus
Aspirin
Administration route: Oral
Creon
Administration route: Oral
Indication: Pancreatitis
Possible Actiq side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-01
Patient: 59 year old male
Reactions: Coma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Novorapid
Duragesic-100
Indication: Pain
End date: 2010-03-30
Lantus
Actiq
Indication: Pain
End date: 2010-03-30
Aspirin
Administration route: Oral
Creon
Administration route: Oral
Indication: Pancreatitis
Possible Actiq side effects in 60 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-29
Patient: 60 year old male
Reactions: Coma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Actiq
Dosage: unk
Indication: Pain
End date: 2010-03-30
Duragesic-100
Dosage: unk
Indication: Pain
End date: 2010-03-30
Lantus
Indication: Diabetes Mellitus
Novorapid
Dosage: unk
Indication: Diabetes Mellitus
Aspirin
Dosage: 75 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Creon
Dosage: 7500 iu, qd
Administration route: Oral
Indication: Pancreatitis
Possible Actiq side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-22
Patient: male
Reactions: Lung Disorder, Overdose, Coma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Novorapid
Indication: Diabetes Mellitus
Lantus
Indication: Diabetes Mellitus
Actiq
Dosage: route: buc
Indication: Pain
End date: 2010-03-30
Creon 25000 IU
Dosage: daily dose: 3 dosage forms
Administration route: Oral
Indication: Pancreatitis
Duragesic-100
Indication: Pain
End date: 2010-03-30
Aspirin
Administration route: Oral
Indication: Antiplatelet Therapy
Possible Actiq side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-21
Patient: male
Reactions: Overdose, Pneumonia Aspiration, Coma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Lantus
Indication: Diabetes Mellitus
Duragesic-100
Indication: Pain
End date: 2010-03-30
Creon
Administration route: Oral
Indication: Pancreatitis
Novorapid
Indication: Diabetes Mellitus
Actiq
Administration route: Oral
Indication: Pain
End date: 2010-03-30
Aspirin
Administration route: Oral
Indication: Platelet Aggregation Inhibition
Possible Actiq side effects in female
Reported by a physician from France on 2011-10-31
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Arrhythmia Supraventricular, Anxiety, Impetigo Herpetiformis, Prinzmetal Angina
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Hydromorphone HCL
Administration route: Oral
Fentanyl-100
Acetaminophen and Tramadol HCL
Morphine
Actiq
Zomig
Other drugs received by patient: Nexium; Prednisone; Acupan; Sufenta Preservative Free; Clonazepam; Butazolidin
|